Market Cap (In SEK)
158.09 Million
Revenue (In SEK)
-
Net Income (In SEK)
-13.69 Million
Avg. Volume
592.84 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.342-1.26
- PE
- -4.09
- EPS
- -0.18
- Beta Value
- 1.081
- ISIN
- SE0009695927
- CUSIP
- -
- CIK
- -
- Shares
- 214506000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Jonas Jonmark
- Employee Count
- -
- Website
- https://www.acucort.com
- Ipo Date
- 2017-04-24
- Details
- AcuCort AB (publ) develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions. It offers Zeqmelit, a medicine used for the treatment of severe and acute allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting, as well as for the treatment of COVID-19 patients who need supplemental oxygen treatment. AcuCort AB (publ) was incorporated in 2006 and is based in Lund, Sweden.
More Stocks
-
DMB
-
NUVBNuvation Bio Inc.
NUVB
-
HUSQ-AHusqvarna AB (publ)
HUSQ-A
-
ROCK-BRockwool A/S
ROCK-B
-
CDP
-
PAAL-BPer Aarsleff Holding A/S
PAAL-B
-
4584
-
AS